Description
RAFASSAL 500 mg enteric-coated tablets are designed to release mesalazine in the colon to treat ulcerative colitis and Crohn’s disease. The coating protects the drug from stomach acid, ensuring delivery to the site of inflammation.
Enteric-coated mesalazine tablets for IBD.
RAFASSAL 500 mg enteric-coated tablets are designed to release mesalazine in the colon to treat ulcerative colitis and Crohn’s disease. The coating protects the drug from stomach acid, ensuring delivery to the site of inflammation.
Reviews
There are no reviews yet.